#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Scleroderma associated digital ulcer Immune-mediated enterocolitis Burkitt's lymphoma refractory Asthma Idiopathic pulmonary fibrosis Soft tissue sarcoma Epstein-Barr virus associated lymphoproliferative disorder Leukaemia Cold type haemolytic anaemia Hydrocephalus Henoch-Schonlein purpura Biliary neoplasm Autoimmune myositis Pancreatic carcinoma KBG syndrome More trials…

    Learn about Rare Diseases

    Osteosarcoma recurrent – Life with Disease Mantle cell lymphoma refractory – Trials in Disease Angiosarcoma non-metastatic – Trials in Disease Factor IX deficiency – Life with Disease Toxic epidermal necrolysis – Life with Disease Undifferentiated sarcoma Langerhans’ cell histiocytosis – Basic Information Myelodysplastic syndrome – Basic Information Wiskott-Aldrich syndrome Antisynthetase syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Imatinib Mesilate For-6219 Efanesoctocog Alfa Treosulfan Iph6501 Nizatidine GSKVX000000034792 Anastrozole Sertraline Hydrochloride Clonazepam Human Mesenchymal Stem Cells Valganciclovir Hydrochloride Teriparatide X-396 GSK5784283 Abacavir Sulfate Ciclosporin Delafloxacin VX-993 Progesterone Ph. Eur. More therapies…

    Learn about Your Condition

    Epidermolysis bullosa Hyperlipidaemia Nodular melanoma Raynaud's phenomenon Immunodeficiency congenital Major depression Cutaneous calcification Diabetic ketoacidosis Radiation skin injury Transient ischaemic attack Cholestatic pruritus Cervical dysplasia Myositis Cough Endocrine disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Mental Disorders

  • Study of flortaucipir and florbetapir in patients with memory disorders including Alzheimer’s disease and dementia

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Florbetapir (18F)
    • Flortaucipir (18F)
    France

  • A study of azetukalner compared to placebo for adults with moderate-to-severe major depressive disorder

    Recruiting

    3 1
    Investigated Drugs:
    • Azetukalner
    Czechia Finland Germany Poland Romania Slovakia +1

  • A study testing xanomeline tartrate and trospium chloride added to current treatment for adults with bipolar I disorder experiencing mania

    Recruiting

    3 1
    Investigated Diseases:
    • Bipolar I disorder
    Investigated Drugs:
    • Trospium Chloride
    • Xanomeline Tartrate
    Bulgaria Denmark France Italy Poland Romania

  • Long-Term Safety Study of Direclidine in Adults with Schizophrenia

    Recruiting

    3 1 1
    Investigated Diseases:
    • Schizophrenia
    Bulgaria Hungary Romania

  • A study testing intranasal esketamine compared to midazolam for rapidly reducing symptoms of major depressive disorder in adolescents with suicidal thoughts or behavior

    Recruiting

    3 1 1
    Investigated Diseases:
    • Major depression
    Investigated Drugs:
    • Esketamine
    • Midazolam
    Hungary Italy Romania Spain

  • A study testing direclidine compared to placebo in adults with schizophrenia who need hospital care

    Recruiting

    3 1
    Investigated Diseases:
    • Schizophrenia
    Bulgaria Hungary Romania
Previous Page
1 2 3 4 5 … 40
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!